AbbVie Inc. - notizie pubblicate 394 - letture 16.043
ABBVIE INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ABBVIE INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ABBVIE INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ABBVIE INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ABBVIE INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ABBVIE INC.
AbbVie to Present at the Bank of America Securities Healthcare Conference
Corporate news may 06, 2024 abbvie to present at the bank of america securities healthcare conference open a printable version of this page email the url of this page to a friend n ...
ABBVIE INC.
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
Abbv-20240331 united states securities and exchange commission washington, d.c. 20549 form 10-q (mark one) ☒quarterly report pursuant to section 13 or 15(d) of the securities exc ...
ABBVIE INC.
AbbVie Reinforces Commitment to Science and Innovation with a €150 million Euro Investment in New Cutting-Edge Research and Development Facility in Germany
April 30, 2024 abbvie reinforces commitment to science and innovation with a €150 million euro investment in new cutting-edge research and development facility in germany open a ...
ABBVIE INC.
AbbVie Reports First-Quarter 2024 Financial Results
Corporate news april 26, 2024 abbvie reports first-quarter 2024 financial results open a printable version of this page email the url of this page to a friend reports first-quarter ...
ABBVIE INC.
AbbVie Reports First-Quarter 2024 Financial Results - Form 8-K
Abbvie reports first-quarter 2024 financial results •reports first-quarter diluted eps of $0.77 on a gaap basis, an increase of 492.3 percent; adjusted diluted eps of $2.31, a de ...
ABBVIE INC.
AbbVie Reports First-Quarter 2024 Financial Results
Press release abbvie reports first-quarter 2024 financial results reports first-quarter diluted eps of $0.77 on a gaap basis, an increase of 492.3 percent; adjusted diluted eps of ...
ABBVIE INC.
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
Immunology r&d news april 25, 2024 new data show rinvoq® (upadacitinib) demonstrated superiority versus dupixent® (dupilumab) across primary and all secondary endpoints in an ...
ABBVIE INC.
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Immunology r&d news april 18, 2024 phase 3 select-gca study of upadacitinib (rinvoq®) showed positive results in patients with giant cell arteritis open a printable version of ...
ABBVIE INC.
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Neuroscience r&d news april 12, 2024 abbvie announces late-breaking data at aan supporting long-term safety and efficacy of atogepant (qulipta®) for preventive treatment of mi ...
ABBVIE INC.
AbbVie to Host First-Quarter 2024 Earnings Conference Call
Corporate news april 04, 2024 abbvie to host first-quarter 2024 earnings conference call open a printable version of this page email the url of this page to a friend north chicago, ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti